Parallel drugs from EU can be marketed in the UK

The UK Parallel Import Licensing Scheme allows medicinal products authorised in other EU Member States to be marketed in the UK, provided the imported products have no therapeutic difference from the equivalent UK products.

VIEW THE SOURCE